Skip to Content

LAMISIL 250 (Lamisil 250 mg)

Generic Name: terbinafine

Pill with imprint LAMISIL 250 is White, Round and has been identified as Lamisil 250 mg. It is supplied by Novartis Pharmaceuticals.

Lamisil is used in the treatment of onychomycosis, toenail; tinea capitis; cutaneous candidiasis; onychomycosis, fingernail; tinea corporis (and more), and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy. Lamisil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LAMISIL 250

Lamisil 250 mg LAMISIL 250 Front
Lamisil 250 mg LAMISIL 250 Back
Lamisil 250 mg LAMISIL 250
Lamisil 250 mg LAMISIL 250

Lamisil

Generic Name:
terbinafine
Imprint:
LAMISIL 250
Strength:
250 mg
Color:
White
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antifungals
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals
Inactive Ingredients:
silicon dioxide
hypromelloses
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
55289-0513 PDRX Pharmaceuticals Inc. (repackager)
54868-4008 Physicians Total Care Inc. (repackager)
49999-0466 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide